Issue
Korean Journal of Chemical Engineering,
Vol.30, No.3, 675-679, 2013
Synthesis of new phosphate derivative of benzothiazole and its inhibiting effect on two series of human neuroblastoma cell growth
The sodium salt of di ((1-hydroxy-2-benzothiazolium-1-yl) ethyliden-1,1-H-bisphosphonic acid) orthophosphate was synthesized and its toxicity and viability effects screened on two different human neuroblastoma cell lines. This novel derivative of benzothiazole provides a new compound in connection with research and therapeutic application for tumor cell growth inhibition. Benzothiazole was alkylated in reaction with bromoacetic acid and then converted to its H-bisphosphonic acid derivative in presence of H3PO3/POCl3. The procedure led to formation of two molecules of corresponding H-bisphosphonic acid which attached together via a phosphate bridge. The investigated compound exhibits activities (IC50 value) ranging from 14-23 μM (corresponding to human neuroblastoma SK-BE (2) and SK-NM-C cells).
[References]
  1. Reszka AA, Rodan GA, Mini. Rev. Med. Chem., 4, 711, 2004
  2. Green JR, Oncologist,, 9(Suppl. 4), 9, 3, 2004
  3. Martin MB, Grimely JS, Lewis JC, Heath HT, Bailey BN, Kendrick H, Yardley V, Caldera A, Lira R, Urbina JA, Moreno SNJ, Docampo R, Croft SL, Oldfield E, J. Med. Chem., 44, 909, 2001
  4. Yardley V, Khan AA, Martin MB, Slifer TL, Araujo FG, Moreno SNJ, Docampo R, Croft SL, Oldfield E, Antimicrob.Agents Chemother., 46, 929, 2002
  5. Martin MB, Sanders JM, Kendrick H, de Luca-Fradley K, Lewis JC, Grimely JS, Van Brussel EM, Olsen JR, Meints GA, Burzynska A, Kafarski P, Croft SL, Oldfield E, J. Med.Chem., 45, 2904, 2002
  6. Sanders JM, Ghosh S, Chan JMW, Meints G, Wang H, Raker AM, Song Y, Colantino A, Burzynska A, Kafarski P, Morita CT, Oldfield E, J. Med. Chem., 47, 375, 2004
  7. Riebeling C, Forsea AM, Raisova M, Orfanos CE, Geilen CC, Br. J. Cancer., 87, 366, 2002
  8. Forsea AM, Muller C, Rieibeling C, Orfanos CE, Geilen CC, Br. J. Cancer., 91, 803, 2004
  9. Kitagawa Y, Hiraga T, Yura Y, Yoneda T, Oncol. Rep., 13, 211, 2005
  10. Chuah C, Barnes DJ, Kwok M, Corbin A, Deininger MWN, Druker BJ, Melo JV, Leukemia., 19, 1896, 2005
  11. Roelofs AJ, Thompson K, Gordon S, Rogers MJ, Clin Cancer Res., (Suppl. 20),, 12, 6222s, 2006
  12. Kimmel DB, J. Dent Res., 86, 1022, 2007
  13. Luhe A, Kunkele KP, Haiker M, Schad K, Zihlmann C, Bauss F, Suter L, Pfister T, Toxicol. In Vitro., 22, 899, 2008
  14. Erez R, Ebner S, Attali B, Shbat D, Bioorganic & Medicinal Chemistry Letters., 18, 816, 2008
  15. Maris JM, Matthay KK, J. Clin. Oncol., 17, 2264, 1999
  16. Kiran YB, et al., European J. Med. Chem., 43, 885, 2008
  17. Dubois SG, Kalika Y, Lukens JN, J. Pediatr. Hematol. Oncol., 21, 181, 1999
  18. Sohare Y, Shimada H, Scadeng M, Pollack H, Yamada S, Ye W, Reynolds CP, DeClerck YA, Cancer Res., 63, 3026, 2003
  19. Widler L, Jaeggi KA, Glatt M, Muller K, Bachmann R, Bisping M, Born AR, Cortesi R, Guiglia G, Jeker H, Klein R, Ramseier U, Schmid J, Schreiber G, Seltenmeyer Y, Green JR, J. Med.Chem., 45, 3721, 2002
  20. Takeuchi M, Sakamoto S, Yoshida M, Abe T, Isomura Y, Chem. Pharm. Bull., 41, 688, 1993
  21. Takeuchi M, Sakamoto S, Kawamuki K, Kurihara H, Nakahara H, Isomura Y, Chem. Pharm.Bull., 46, 1703, 1998
  22. Lavielle G, Hautefaye P, Schaeffer C, Boutin JA, Cudennec CA, Pierre A, A. J. Med. Chem., 34, 1998, 1991
  23. Smith AB, Taylor CM, Bencovic SJ, Hirshmann R, Tetrahedron Lett., 35, 6853, 1994
  24. Turhanen P, Vepsalainen J, Beilstein J. Org. Chem., 4, 7, 2008
  25. Kiran YB, Devendranath Reddy C, Gunasekar D, Suresh Reddy C, Annette Leon, Luiz CA, Barbosa C, European J. Med. Chem., 43, 885, 2008
  26. Turhanen PA, Vepsalainen JJ, Synthesis., 13, 2119, 2005
  27. Turhanen PA, Ahlgren MJ, Jarvinen T, Vepsalainen JJ, Synthesis., 4, 633, 2001